Search results
Stock Market Today: Dow rides broadening out of rally to notch 4th weekly win By Investing.com
Investing.com· 6 days agoInvesting.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out...
Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall By Investing.com
Investing.com· 5 days agoMidday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 6 days agoThe adjustment follows a review of Moderna's first-quarter performance, which reported steady...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 6 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Stock Market News for May 14, 2024
Zacks via Yahoo Finance· 1 day agoAverage (DJI) fell 0.2% or 81.33 points to close at 39,431.51. Notably, 13 components of the 30-stock index ended in negative territory, while 17...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most...Securities ...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoDespite these impressive numbers, a deeper look into the company's financials reveals a Loss Per Share of 15.67. This analysis aims to determine whether Moderna's
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall